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The intimate relationship as a site of social protection:  Partnerships between 
people who inject drugs  
 
 
 
ABSTRACT 
Public health research treats intimate partnerships as sites of risk management, including in the 
management of HIV and hepatitis C transmission. This risk-infused biomedical approach tends to 
undermine appreciation of the emotional and socially situated meanings of care in intimate 
partnerships. In this article we explore qualitative interview accounts of the care enacted in 
partnerships between people who inject drugs, drawing on a 2014 study of 34 couples and 12 
individuals living in two locations of Australia. A thematic analysis highlights ‘best friend 
relationships’, ‘doing everything together’, ‘co-dependency’, and ‘doing normalcy’ as core to 
narratives of care. As we will argue, the accounts position the care undertaken by couples as at once 
shaped by day-to-day practices of drug use and by social situation, with the partnership enacting 
care as a form of social protection, including protection from stigma and other environmental 
hostilities. The intimacy of doing everything together offers insulation against stigma, yet also 
reproduces its isolating effects. While the care produced in drug-using partnerships is presented as 
double-edged, we note how interview accounts are used to deflect the charge that these 
relationships represent harmful co-dependency. Taken together, the interview accounts negotiate 
what we call a ‘counter-care’ in relation to normalcy, presenting the intimate partnership between 
people who use drugs as a legitimate embodiment of care.  
 
Key words 
Relationships; Intimacy; Care; Addiction; Injecting drug use; Qualitative. 
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INTRODUCTION 
A growing body of public health research positions the intimate partnership as a tool of risk 
management. The fields of HIV prevention and drug addiction are prime examples of this. Here, 
couple-focused interventions are endorsed as a way of improving engagement in care interventions 
such as testing, counselling and treatment, and of fostering couple-based changes in risk and drug 
use practices (El-Bassel et al., 2014; Jiwatram-Negron and El-Bassel, 2014; Simmons and McMahon, 
2012). Among people who inject drugs, there is growing interest in couple-oriented interventions as 
a means of hepatitis C prevention (Dwyer et al., 2011; Fraser, 2013). A key feature of such couple-
oriented interventions is an attempt to move beyond narrowly-defined psychological conceptions of 
individual behaviour change and self-care towards more broadly conceived social strategies of 
change. This includes rethinking the intimate relationship as a unit of social change and as a resource 
of shared-care in the face of risk or uncertainty (Montgomery et al., 2012; Lewis et al., 2006; Rusbult 
and van Lange, 2003).   
 
In this article we investigate these issues by focusing on the affective care practices enacted within 
partnerships between people who inject drugs who live day-to-day with heroin and other opiate use. 
Rather than framing our analyses in relation to public health infection control, and hepatitis C 
prevention specifically (Rance et al., 2016; Fraser et al., 2015), we pick up on alternative framings of 
care in couples’ accounts of their partnerships. These enact the partnership as a resource of 
protection, both in negotiating a certain way of living as a couple in relation to drug use and 
addiction, and in offering social protection in relation to an inimical world. We thus consider how the 
care practices enacted by partnerships are inextricably linked to their social contexts. 
 
Using accounts generated through in-depth qualitative interviews, we explore the care practices 
enacted by drug-using couples as unavoidably interconnected, and in conversation with, their 
network of social relations. Following Mol (2008), we envisage ‘good care’ as that which is practised 
as an effect of how care is attuned to everyday social relations, interactions and situations. This 
stands in contrast to a logic of care which draws primarily on assumptions of individual autonomy 
and choice through which citizenship and duty of care is enacted in relation to surrounding public 
discourses of care expectation and risk rationality. The emphasis thus becomes describing the care 
practices undertaken within socially situated partnerships, in which individuals and their 
technologies of self-care are but one force. In considering how the affective care practices of 
marginalised intimate partnerships enact social protections in relation to an inimical outside, we also 
emphasise how the accounts of partnerships enact resistance through their narrativisation.  
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Intimacy and care relations 
In our earlier work on couples affected by viral dangers such as HIV and hepatitis C, we highlighted 
how risks and dangers selected for public attention are socially situated. This includes how 
partnerships are negotiated as intimate, meaningful and secure (Rhodes and Cusick, 2000; Seear et 
al., 2012; Fraser et al., 2015). Distinct from a primary emphasis on viral risk, these qualitative studies 
describe alternative frames of rationality in relation to risk, care and safety arising from the 
embodied emotions and everyday pragmatics of partnership. Significantly, they emphasise how 
intimate partnerships can enact a sense of psychic protection from risk or uncertainty, including that 
linked with chronic illness. For example, in the case of living with HIV prior to the advent of 
combination antiretroviral treatments, couples’ accounts presented a sense of shared relationship 
security and destiny realised through intimacy, including through unprotected sex (Rhodes and 
Cusick, 2000). Here, enacting a sense of relationship security is balanced against viral safety in a 
situation characterised by an uncertain future. This work envisages the intimate partnership as a 
local solution to pervasive risk and, in its broader relation to the management of contingency in late 
modernity (Giddens, 1992), casts intimacy as an alternative to doubt when navigating an inimical 
world (Beck and Beck-Gernsheim, 1995).  
 
Care and coping practices enacted in intimate partnerships can thus be interpreted through their 
specific social relations, including patterns of social and material inequality, uneven power dynamics 
and historical location (Wetherell, 2012; Nielsen and Rudberg, 2000; Skeggs, 2004). In this article we 
envisage affective care practices as shaped by their entanglement in a network of connections, 
which pattern together “feelings, thoughts, interaction patterns and relationships, narrative and 
interpretative repertoires, social relations, personal histories, and ways of life” (Wetherell, 2012: 
14). Affective care practices are at once felt and embodied and produced through the habits and 
representations of everyday social interactions. In this respect, we can extend our earlier work on 
HIV health and illness futures (Rhodes and Cusick, 2000), to consider the drug-using couple as a 
relation of affective practice, with its particular social relations and emotional regimes, emotional 
capital and care expectations (Reddy, 2001; Ahmed, 2004).  
   
Care and the drug-using couple 
Research focused on the public health aspects and harms of drug use primarily interpret 
partnerships between people who inject drugs as pragmatically oriented to accessing drugs and 
managing risk, especially HIV and HCV transmission risk and the escalation of drug use (Bourgois et 
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al, 2004; Simmons and Singer, 2006; MacRae and Aalto, 2000). Cast as risk producing, the drug-using 
couple can be presented as a perverse style of care in that the cooperative work in managing drug 
use is seen to diminish rather than enhance health and welfare (Simmons and Singer, 2006; Glick 
Shiller, 1992; Rotunda and Doman, 2001).  While this depiction of such partnerships is often resisted 
(Simmons and Singer, 2006; Rance et al., 2016, 2017), it remains influential (Cavacuiti, 2004), with 
implications for how they are understood and valued. Critically, people who use drugs often express 
awareness that their partnerships are cast as falling short of proper intimate and caring 
relationships.  
 
While it is important to question the reduction of these relationships to pragmatic alliances 
established only to manage day-to-day demands, this is not to deny that such demands do help 
shape those relationships (see for instance, Bourgois, 2009). The urgency that can arise in managing 
withdrawal, the challenges of generating resources and acquiring drugs, the navigation of risks 
(overdose, infections, violence, criminal convictions), exposure to hostile community attitudes and 
social stigma, and the regulation of drug use in relation to other social and partnership roles (such as 
parenting, employment) all shape partnerships (Fraser et al., 2014). Envisaging the drug-using couple 
and the care it enacts as both affected by, and affecting, its network of social relations shifts analysis 
from naturalising discourses that decline to interpret partnerships through their social relations to 
approaches that actively situate them in the social.  
 
             
METHODS 
The analysis conducted here is based on 80 qualitative interviews conducted with people who inject 
drugs (see also, Rance et al., 2016, Fraser et. al., 2015). Participants included 34 couples, each of 
whom were interviewed, and 12 additional individuals, of whom seven were in current relationships 
and five had previous relationships with partners who also injected drugs. Participants were 
recruited from low-threshold drug services in four inner-city locations in two Australian states during 
2012/13. Partners in a couple were interviewed separately by the same researcher, with assurances 
of confidentiality emphasised. We elected to interview partners in a couple separately to facilitate a 
conversational context enabling of talk in relation to partnership dynamics, including of partnership 
negotiations in relation to risk management and care (Eisikovits and Koren, 2010; Rhodes and Cusick, 
2000). This has generated a thematic triangulated analysis of individual partner accounts of their 
shared partnership rather than an analysis of a single negotiated account co-produced with the 
researcher in situ. Participant selection proceeded purposively initially and thereafter theoretically 
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as data emerged, including in relation to: relationship experience; age (although our data set under-
represents younger drug injectors); gender (equally distributed between men and women); and 
reported hepatitis C antibody status (representing a mix of concordant and discordant couples). 
 
Ethics 
The study was approved by the Human Research Ethics Committee of The University of New South 
Wales and from the relevant human research ethics committees at each site. Written, informed 
consent was obtained from all participants. All names reported here are pseudonyms. Each 
participant was reimbursed $30 (Aus) for their time and travel expenses. 
 
Dataset 
Table 1 summarises the study participants. The duration of partnerships varied from two to 20 years.  
Nine participants were in part or full-time employment, with nearly all receiving some form of social 
welfare (n = 71); one participant depended on their partner’s income and two participants declined 
to answer. Over half the participants identified as Anglo-Australian and nearly a quarter as 
Aboriginal or Torres Strait Islander (n = 17). Hepatitis C antibody status was determined by self-
report, and in some cases partners offered conflicting accounts, with 35 reporting themselves as 
HCV-negative and 45 HCV-positive. Of the 41 couples, 24 were HCV concordant (11 HCV-negative 
and 13 HCV-positive) and 17 HCV discordant (10 HCV-positive men and 7 HCV-positive women). Of 
these 41 couples, 29 or just over 70%, reported sharing injecting equipment within their partnership.  
 
Data generation  
Interviews sought to capture participants’ perspectives in relation to their day-to-day practices of 
drug use, health-related risk management, care, and relationships. Interviews took between 30 and 
60 minutes, and were audio-recorded with informed consent for subsequent verbatim transcription.  
An overarching theme in accounts of partnership concerned how they enabled a sense of pragmatic, 
emotional and social protection. This was despite, as well as because of, drugs being a pervasive 
feature of relationship concern. Our approach to coding data and its interpretation was informed by 
a pilot study investigating couples undertaken by the research team (Seear et al., 2012), and by our 
previous work on the production of intimacy within partnerships (Rhodes and Cusick, 2000). Key 
themes emerging through the coding process, and which inform the analysis developed here on how 
partnerships enact care, included: best friend relationships; doing everything together; co-
dependency; and normalcy. We also coded for varieties of care and protection, including that which 
was narrated as pragmatic, emotional and social, and that oriented to within and beyond 
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partnership care. Data coding and management was assisted by computer software (NVivo 9) and 
the generation of initial theme files based around core coding nodes (most germane here were 
those relating to relationships, dependence, and stigma).  
 
Data analysis 
While we acknowledge that our interview approach generated individual partner accounts of 
partnership, our analyses has sought to give primacy to the partnership as the unit of analytical 
interest. To this end, we organised all transcripts as emanating from couples (n=34), including within 
NVivo, such that we were able to follow the thread of the story of the couple, always considering 
each partners’ contribution to their narrative of partnership. To assist this process, each partner was 
given a code identifying them as part of their unique couple, which meant that every data extract 
was immediately indexed to also belonging to a couple.  
 
In addition to our analytical sensitivity to the couple beyond the individual, our interpretations are 
also sensitive to narrative context. We treat our interview data as relational to its situation of 
production, wherein narratives perform and negotiate an identity and agency in a relational context 
of meaning (Riessman, 2003). This enables us to consider the accounting functions which narratives 
may serve and the relational nature of the story told. We investigate qualitative accounts for what 
they represent in relation to partnership affective care practices, and the network of effects 
indicated to shape these, as well as how such accounts seek to legitimise the forms of care they 
represent.  
 
Presentation of analyses 
A key feature of interview accounts is the emphasis they place on how intimacy within partnerships 
between people who inject drugs (primarily heroin) enacts social protection in relation to an inimical 
outside. The intimacy of partnerships is presented as offering insulation from emotional harm linked 
to surrounding social stigma. Awareness of the drug-using couple being represented as harmful and 
improper is a key element of this. We interpret these interview data below in relation to two linked 
domains: intimacy as a resource of protection; and accounting as a resource of legitimation.    
           
INTIMACY AND PROTECTION 
The first narrative we analyse here is that of intimacy as protection. As we will argue, the accounts 
pose intimacy as a protective resource. The overlapping notions of ‘best friend relationships’ and 
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‘doing everything together’ are core to the narrative of how intimacy serves to accommodate as well 
as protect drug-using partnerships in relation to their surrounding social situation. 
 
Best friend relationships 
Many participants depicted their partnerships in romantic terms (“I adore him. I love him so much”, 
Janine; “I love him. […] He’s just the most beautiful person I’ve ever met in my life”, Crissy). In 
addition, however, partnerships were commonly constituted as best friendships: “We’re best 
friends” (Fran, Belinda); “We’re the best of friends” (Samantha); “He’s my best friend” (Lisa); “She’s 
my best friend” (Patrick); “She’s my best mate, has been for twenty years” (Cliff). Those casting their 
relationships as romantic often also presented them as friendships (“She’s my best friend, she’s my 
lover, she’s my partner and my companion”, Seth). Yet, for some, best friendships and romance 
were distinct: “We’ve just been more friends than we have, you know, partners” (Nigel); “It’s more 
just a friendship” (Clare); “More friends now, than anything… We get on better as friends” 
(Samantha).  
 
In this depiction of best friend relationships, there is a sense of displacing (though time) or 
discounting (though drug use) romantic relationship potential, as a result of the day-to-day demands 
and routines of drug use. Fran explains that in her partnership with Fred drug use “takes over 
everything else” and is “just a constant”. Fred sees this as limiting their relationship potential: “Look, 
we’re on a good friends basis and, like, we’re not going to get married, but we’re together, and 
we’ve been together for about eight years”. He goes on to say, “I do want to spend my life with her, 
but she’s still in the immediate stage of her drug addiction… She likes the drug and that’s something 
that we have to get over”. While Fred is “just hoping she’ll hurry up” and “come to her senses and 
realise enough is enough”, and indicates that he is “running out of patience”, his is an “unconditional 
love, no matter what happens”.  
 
It has been posited that relationships which are sustained through intimate and intense interaction 
with another based around the mutual satisfactions and pleasures that such relationships enable are 
more like ‘friendships’ (Giddens, 1992; Jamieson, 1998). Giddens (1992) offers the notion of the 
‘pure relationship’ as one based primarily around the realisation of mutual pleasures and which 
protects itself from falling back to more traditional ways of partnership, including that defined by 
being a romantic couple. It is important to recognise that intimacy is enacted in multiple ways, 
including through pragmatic engagements linked to the everyday routines, shared activities and 
chores of partnership. Drug use can be a core momentum for best friendships, but these 
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partnerships are no less intense or intimate. As Cliff says, “We’ll be together until the day we die… 
She is my lifelong mate”. Similarly, Tim emphasises that he’d “kill and die for that girl”. 
 
As with Fred and Fran, Tim’s partnership with Tanya is organised to a significant degree around drug 
use. The habits, pragmatics and pleasures of drug use are core elements of the mutual satisfaction 
their relationship brings. Yet his account also comments directly on the fragility of such best friend 
relationships. Of the eight years they have been together, Tim says, five “were absolutely beautiful” 
but the last three have seen his partner show “more love for [drugs] than for me”. Tanya says in turn 
that “he’s always either trying to get the next fix or trying to sort it out”. He is, she says, “very greedy 
and it’s only for him”.  
 
We can interpret these narratives of best friendship as accounts of accommodation, for they accept 
the shared immediacy, even primacy, of drug use. For some (like Fred) this is until such time as  
drugs take less precedence. Equally, the narrative of best friendship circumvents the trope of 
partnership as primarily a performance of romance in presenting intimacy as rooted in the mutual 
satisfactions of everyday activities such as drug use. The ‘pure relationship’, as imagined by Giddens 
(1992), is a ‘post-traditional’ relationship, somewhat detached from its material and social relations. 
It is an equal partnership enacted purely through the intimacy derived from the realisation of mutual 
pleasure. Here, we see a counter-narrative of the couple produced through the notion of best friend 
relationships organised in relation to drug use. The narrative of best friend relationship seeks to 
balance the pragmatics and emotions, as well as fragilities, of partnerships affected through, and 
affected by, drug use. As we will go on to see, these relationships are far from pure in the sense of 
being detached or protected from their social relations.  
  
The ‘everything together’ of care and protection 
A striking characteristic of how partnerships were presented in the interviews is their totalising 
effect on everyday social interactions. Almost without exception, accounts emphasised constant 
unity: “We do everything together” (Les); “Absolutely everything” (Samantha); “Every second of 
every day” (Mike). Unsurprisingly, these strongly united partnerships give rise to a pronounced logic 
of sharing: “If you’re in a relationship, then it’s 50-50 on everything” (Cliff); “Once you’re a couple, 
that’s it, you have to share everything” (Jim). For Jim, this “everything together” dynamic de-
emphasises individuality in favour of shared experience: “We’re two partners become one. We’re in 
it together” (Jim). One consequence of this intensity of contact and logic of sharing is intimacy and 
trust: “We know everything about each other” (Dan); “We don’t have any secrets” (Lisa); “By sharing 
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in the relationship, it’s a way of just showing absolute trust” (Belinda). The everything-together 
approach to partnership is an all-encompassing relation of care and protection:  
 
We’ve been together, well, half way through August will be 10 years. We met, and ran into 
each other the next day, and we’ve spent every night, every day, together since… He’s my 
rock, he’s always been there. (Charlie).  
 
We’ve been injecting together since, almost since we started seeing each other. We’re very 
much obsessed with each other, and so spend 90% of our time together. We look after each 
other, you know, financially, emotionally. (Jack) 
 
We met at rehab, and we’ve been together 10, about 10 years… It’s just the two of us, and 
we’re best friends. We only have each other, and we’re very lucky to have someone to 
bounce things off, and yeah, without him, I don’t think I’d be here. (Belinda) 
 
The above accounts suggest partnerships established in a context of drug use quickly become 
consuming, and function thereafter as indispensable mutual care and support. Such partnerships 
provide affective capital in an uncaring world (“We only have each other”). This care potential is 
highly valued: “He’s so gentle, and caring, and loving, and understanding. […] He’s a beautiful human 
being. He’s got a beautiful heart. He’s very caring and I’ve never met anyone like him in my life” 
(Suzie). Crucially, the care that is enacted through this everything together of partnerships is not 
detached from its ‘outside’ but shaped in relation to it. Interview accounts emphasise the coming 
together of partners into a care relation as an effect of the particularities – and difficulties – of drug 
use and its wider social and material relations. Drug-related and other material troubles can be the 
making of care relationships. For example, Jenn describes how her partnership emerged in relation 
to homelessness:      
 
It started off as a friendship, ‘cause we were on the street, and he really helped me. We 
were both kind of street, and we got to know each other, and so it was kind of really based 
on the friendship, and then kind of helping each other, and we both had a (drug) habit… It 
was kind of like, that kind of thing, looking after each other, because it’s hard, I think it’s 
hard, I think it’s harder on your own. (Jenn) 
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Jenn’s account emphasises shared troubles as a defining feature of the care that partnerships 
provide: “When you’re on the street with someone and you go through such a full-on experience 
together, you know what I mean, you kind of really bond… because we’ve been through so much”. 
Similarly, Belinda says of her partner Bob: “The only friend, the only person who understands who I 
really am”. And as Roger says: “I’ve got family and all that, but when it comes to this… she’s 
everything” (Roger). This care dynamic of everything-together emerges relationally; an effect of felt 
‘difference’ from the ‘normal’, of exclusion, of detachment, and of otherwise being alone:   
 
When you're normal it’s different. But when you're using, I think, because you need 
somebody, it’s better than being on your own, it helps you help each other. You know what I 
mean, kind of thing, with money, and this, and the emotional support. (Fran) 
 
It is here also that we can appreciate how intimate and affective practices are enacted through the 
pragmatics of partnership. The day-to-day shared care of generating income for drugs, sourcing and 
sharing drugs, moderating drug withdrawal, managing overdose, avoiding police, negotiating social 
harms, and injecting safety are at once pragmatic and emotive, both enacting the difference and 
everything-together of drug-using partnerships. As Belinda says: “If one is sick (in withdrawal), the 
other is sick. If one goes out to make money, the other goes out to make money as well. It’s always 
100% together. That’s the commitment we made from the beginning, and I’ll stick to that until I die”. 
Fred too explains: “We make sure one another is all right. We try to, we pool in together, to make it 
easier. If she is sick, I’m there for her. If I’m sick, she’s there for me”.    
 
The everything-together of care is also an enactment of social protection; it serves to accommodate 
and negotiate a hostile outside which excludes, stigmatises, and undermines. Fran says her 
relationship operates as a “kind of bubble”. Libby describes her partner as  a “soul mate” to “help 
get through every day”. Jenn’s account merges together her material concern about managing drug-
related risk (in this case, overdose) with a more general sense of her partnership as a buffer against 
social isolation (which the everything-together of partnership may serve to reproduce):  
 
I haven’t used on my own in a long time and just having him there I know at least if I 
overdose I’ll be OK. I trust him completely, and just kind of, I think safety. Like I feel you 
know, just having somebody there, because we have been using a lot, we’ve kind of been 
very isolated, like don’t really see many people, lost kind of friendships, so it’s kind of like, 
that’s why we kind of relied on each other for everything. (Jenn)  
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Jim, Jenn’s partner, similarly envisages their partnership as a “break up from the pack”. Borne out of 
their social relations of difference, these partnerships may have weaker economic and material ties 
to the outside. The everything-together of care may constitute resistance to conventional devaluing 
of drug-using partnerships, or cushion against social exclusion, but it would seem to reproduce the 
social isolation it seeks to address:  
 
It’s safer, but then again, you’re cut off from the world. It’s like couples think, ‘Oh, we’re 
better, we’ve got each other’. Like you’re in a safer environment, but you’re not… Actually 
you’re not getting the help you need, and you’re just forgetting about everyone, and just 
sticking to you two. You can just run away with each other, and the world just goes by. (Jim) 
 
We interpret the doing of everything together as an effect of, and response to, the stigmatisation of 
drug users and the de-valuing of their partnerships. Yet the narrowing of attention to the 
partnership may entrench a sense of distance from the world going by. The doing of everything 
together may be seen as a form of resistance in defence of living an alternative life (one in which 
drugs are a core feature of the relation), as well as momentary retreat from the symbolic violence 
and material hostilities linked to a life with drugs. The shared-care of everyday drug use activity – 
raising income, purchasing, sharing, using, managing risk – is thus at once pragmatic and emotional. 
This is the “common cause” of an intimate partnership based in difference (Beck and Beck-
Gernsheim, 1995). Its intimacy is a practice of care because navigating drug-related troubles and 
material hardships necessitates partnership rather than sole survival (for instance, through the 
pooling of material and emotional resources), but also because it lends these partnerships specific 
affective meaning. 
 
ACCOUNTING FOR CARE IN PARTNERSHIPS 
A key issue identified in our analysis is the marked attention participants pay to challenging or 
deflecting the negative connotations of their partnerships and to accentuating their normalcy. 
Envisaging qualitative accounts as acts of performance is helpful here. In doing so, we can recognise 
how interview narratives work to negotiate the legitimacy and relative normalcy of otherwise 
marginalised partnerships.  
 
Accounting for co-dependency 
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While participants emphasise the care that defines their relationships, they often raise questions 
about such relationships in general and suggest that they can generate perverse forms of care. Here 
we see the language of co-dependency, once not uncommon to psycho-behavioural therapeutic 
explanations of dependency-related harm (Haaken, 1990) emerge. For instance, Seth and Jenn both 
temper their accounts of their partnerships as caring with a normative therapeutic concern about 
co-dependency as bad. In doing so they deflect a possible charge that the everything-together of 
their relationships is harmful: 
 
I share everything with her. It might be a bit co-dependent in other people’s eyes. I don’t 
mind saying we help each other. I think that’s always a positive thing. We’re not lonely 
because we have each other to turn to, so I think that again is a healthy thing. It’s a beautiful 
relationship. (Seth) 
 
When people say like, if they see me by myself, they’re like ‘Where’s, where’s Jim?’ You 
know what I mean. Or they think something’s wrong… I don’t like that about it you know, 
because I kind of feel really co-dependent. I feel like I lose my identity a bit, but I mean, what 
can you do? Take the good with the bad. As much as that’s bad, there’s so many good things 
about being in a relationship. (Jenn) 
         
In some cases, participants explicitly engaged with questions about the potential for co-dependency 
in partnerships between people who use drugs:  
 
I love him to death and I love being with him, but the, we’re, we’re very um, aware of um, 
let’s see, you know, being co-dependent and all that stuff. Um, we’ve both like, done a lot of 
you know, therapy… We’re pretty tuned in like with what’s going on. (Grace) 
 
Grace’s account has a confessional quality. It presents her as in tune with therapeutic concerns that 
her loving partnership is instead potentially harmful. In this way, narratives of caring partnership 
must somehow bridge a tension between good and bad dependency. Andy admits that he has “a 
very co-dependent relationship, which is bad in some ways, but is good in other ways”, and Jenn 
likewise says “I think it’s good that we’re together, and other times I think it’s not good”, but 
“actually, as much as we’ve hindered each other, we’ve helped each other”.  
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The participants also addressed directly the potential ‘bads’ of drug using partnerships. Fran and 
Mandy, for instance, both depict their partnerships as having become consumed by, or dependent 
on, drug use:  
 
It’s kind of become because of the drug use. It’s become bad in a way, because it’s kind of 
become, we’ve become co-dependent on each other, and kind of we use together so it’s 
kind of at least, if something happens you know, it’s kind of a bit unhealthy in that way, 
because we depend so much on each other. It’s the using [that] plays a big part of it. (Fran) 
 
It’s all based around drugs. […] From the very start, it’s all about drugs. We haven’t really 
had a chance to get straight and see each other in a different clear mind… There’s nothing 
that we really do except going to buy drugs and use drugs together. (Mandy) 
 
In a similar fashion, Sandra laments her partnership as a “drug relationship”. The object of the drug 
is a key partner here. Fred, Fran’s partner, sees drugs as a pivotal actor and pervasive presence in 
their partnership, always positioned between them, so much so that Fred questions whether they 
have any intimacy together beyond the drugs:   
 
It’s like déjà vu, every day. It’s like just the same in and out, day in day out. And it’s an ugly 
routine. And you start to fall behind in life and bills, and just your friends are moving forward 
and I'm staying back. And it’s the worst scary place to be, because it’s quite lonely at the end 
of the day. Even now with my partner, we can’t connect because of it. It’s always in the 
middle of us, daily. We can be so much in love but at the end of the day if we’ve been 
together eight years on drugs as soon as we stop and stay on scratch, so you're really not 
together, you are, but the drug is in the middle. [Fred] 
 
Jenn also presents the drug as a central element of her partnership’s interdependency, extending 
beyond the humans involved. She says that “when you are using… you tend to be needy, and maybe 
a bit more kind of co-dependent”. She emphasises that “you don’t want to be [or] have to be like 
that, of course, but it just kind of happens”. Here, the drug shapes partners’ agency to some extent; 
enacting effects beyond reasoned action (‘don’t want to’) but not entirely (‘don’t have to’). This 
interdependency of drug-human partnership is cast as common to such relationships: “It’s just the 
same [with] all the relationships I’ve seen where people use”. For some then, alongside its human 
co-dependents, the drug is an architect of relationships, shaping their everyday momentum. This 
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generates reflection on the ‘substance’ of these relationships. In Mandy’s account presented above, 
she speaks of losing sight of the meaning of her relationship, while Fred says his relationship is 
somehow less real or its true potential is being postponed.  As Jenn ponders:  
 
It keeps you together in a way… Am I here for the right reasons, or am I just kind of, because 
it’s easier? I do think that sometimes. Because it’s easy. We just kind of keep going… But I do 
really love him. (Jenn)    
 
The incorporation of the drug as a substantive actor in the partnership invites us to think of the drug 
as acting alongside multiple other human and non-human actors (Duff, 2013, 2014). The partnership 
is constituted from multiple actants, which in addition to the humans involved incorporates drugs, 
discourses of stigma, love and care, discourses of dependency and addiction, and so on. For all their 
caring potential, participant accounts tend to frame their everyday relationship troubles in relation 
to the object of drugs. Here, drugs are presented as having destructive potential in that they can 
entrench risks and heavy drug use: 
 
We’ve tried many times together to quit, and we have dragged each other down. There 
were times when she wanted to quit I wasn’t ready, and times when I was ready but she 
wasn’t. But all in all, I think being together has been safer, and we’ve been able to cope, I 
think, being together. (Bob) 
 
If one person wants to stop and the other doesn’t, how do you fucking deal with that? Or 
work around it? Because it’s almost impossible without causing some initial trouble in the 
relationship. (Janine) 
 
This is an acknowledgement of the “double-trouble” of living relationships of interdependence: 
 
Once you’re a couple, that’s it, you have to share everything. You go halvies and everything 
you share. But, you know, unfortunately heroin couples, they rely on each other too much, 
so they become married straight away. It’s like when you become an addict and a couple it’s 
like double-trouble… It sort of gives you the green light, because you’ll both agree we’re 
gonna use together, we’re gonna go and start making money together, and the ball rolls. 
(Jim) 
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Despite these reservations most remark that they are “lucky” to have met their partners and to have 
such partnerships, and they accentuate the work they invest to protect them.  This communicates a 
sense of need – pragmatic and emotional – which is catered for by relationships borne out of 
accommodation to their situation. Protecting the ‘good’ of the care relations of partnerships seems 
paramount: “We give each other heaps of shit, every now and again, but you know, she’s always 
there for me, and I’m always there for her” (Cliff); “I think we both worked really, really hard to be 
where we are today” (Barbara). 
 
In these narratives of co-dependency we see the everything-together approach to relationships 
acknowledged as a potential bad, but only in relation to the goods of care. Critically, we find that 
while some speak of co-dependency, they primarily challenge it, emphasising that the care and 
protection produced in relationships outweigh the bads as others might present them. While the 
accounts do not ignore the tendency for everything-together partnerships to have their “up and 
downs” or drug-related harms, they nonetheless insist that these relationships are to be protected 
and defended. In this respect, they form a counter-narrative in the negotiation of what partnerships 
should be.  
 
Doing normalcy 
Lastly, the accounts generated by this study also emphasise the relative normalcy of their 
partnerships. Participants describe their relationships in prosaic terms: “We read a lot, we talk, we 
plan, we just stick together” (Craig); “We walk, we go to the beach sometimes, just walk around the 
city” (Mac); “We watch a lot of movies together, listen to music” (Simon); “We watch a lot of films, 
we cook dinners together, we share a lot of the same friends” (Janet)“. Indeed, some accounts 
exhibit a reflexivity in relation to the doing of normal things: “We like to go for walks to the beach, 
parks, stuff like that, trying to do as much barbecues, normal stuff, what people call normal” 
(Rachel). These enactments of the normal are, of course, situated alongside habits linked to drug 
use. While Seth says “We love watching movies together, reading, and getting involved with our 
church”, he also remarks “Well, funnily enough, our life is quite involved with clinics and picking up 
our medicine” (Seth). Les comments that he and his partner Libby “watch TV”, “eat”, and “talk”, 
while Libby says that “I think the only thing we really like doing together is using drugs” (Libby). 
Some participants may make extraordinary efforts to do ordinary things. As Natalie explains: 
 
To make us feel that little bit normal, we go down to [city restaurant] to have dinner and 
lunch and stuff, or have breakfast. And it’s the littlest thing, but it makes us feel normal… It 
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started like basically depressing me because it was like the one thing [drug use] that we’d 
always do. I said ‘There is not anything normal that we ever do, like we don’t do anything 
normal like couples do. They go on dates or take you out for dinner’… It was good, like just 
making me feel that bit better… So, at least we got that normal thing together. (Natalie)  
 
Maintaining a sense of normality in partnerships where drugs are a key element can take work, and 
this work features as part of the up and down of relationship negotiations. Tanya, who describes 
living in her partnership as a “rollercoaster” because “drugs have gotten in the way”, likes “going on 
ferry rides… to the movies… [to] the park and reading on a nice day… and […] to the beach with 
[Tim]”. But Tim “just won’t do that, that’s too much for him, I got him to do it [go to the beach] twice 
in nine years”. As she explains, “Our lifestyle has been a lot more of just chasing, surviving, in terms 
of not being sick, because that is survival for most of us… Our lives are so consumed by the lifestyle”. 
Tim reflects that the consuming nature of drug use in their partnership, and their distance from 
normalcy, risks diluting its fundamental substance, making it less real: “I try to have a proper, real, 
relationship with her, but in our lifestyle it’s just difficult at the moment” (Tim). Rachel and Belinda 
also lament how the drug in their relationships renders normalcy more remote:  
 
Drugs, that’s the sad part. As I said to him a couple of weeks ago, we don’t do nothing 
normal together, like go to the pictures, go for tea, go to you now see a film. Normal things 
like normal people do. It doesn’t happen with us. (Rachel) 
 
It’s just we are unable to function without the drugs… I wish it could be like that every day. 
(Belinda)    
 
In these accounts we can see many efforts to overcome the challenges of enacting care in 
partnerships dominated by drug use. Appeals to normalcy reflect the experience of difference and 
detachment that characterises drug using partnerships. These are narrated as partnerships at once 
the same as any other (in descriptions of doing, and wanting to do, normal things) but also different 
from them (in their distance from, or incapacity to do, normal things). It is the legitimacy of 
relationships that are the same but different which is in negotiation when accounts seek to deflect 
the charge of double-edged care.      
 
 
CONCLUSIONS 
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In public health research intimate partnerships between people who use drugs have been addressed 
primarily as sites of risk surveillance and care intervention (El-Bassel et al., 2014; Montgomery et al., 
2012; Dwyer et al., 2011; Fraser, 2013) and risk management of drug dependency (Rhodes and 
Quirk, 1998; Simmons and Singer, 2006; Bourgois et al., 2004). Here, the couple is envisioned as a 
technology of public risk management, often linked to infection control. In this article, we have 
departed from this approach to focus more directly on the partnership itself and what it means for 
those engaged in it. To do so, we have taken partnerships between people who inject drugs 
(primarily heroin) as a case study for exploring qualitatively how care is enacted. Overall, our analysis 
identifies the intimate partnership as a practice of care in its social relations (Wetherell, 2012; 
Burkitt, 2014). These intimate partnerships produce alternative affective value linked specifically to 
the pragmatics and emotions of life with drug use. They enact care through enabling a resource of 
protection to a form of partnership conduct questioned from an inimical outside. Intimacy enacts 
social protection, upholding alternative values of affective care practice while cushioning isolated 
and stigmatised individuals from emotional harm.  
 
We can draw some additional linked conclusions. First, people who use heroin regularly must 
navigate extremely hostile social environments, characterised by multiple forms of risk, violence, 
stigma and insecurity (Bourgois, 2009; Singer, 2004). This involves living against the trope of the 
‘junkie’ and normative constructions of ‘addicts’ as less than full citizens who are positioned as 
incapable of conducting proper relationships given their perverse preoccupation with drugs (Keane, 
2004; Seear et al., 2012). Critically, such social stigma is incorporated as structural violence through 
material and welfare inequalities – for instance, linked to access to income, employment, housing, 
and treatment – which can create a pervasive state of fragility demanding a focus on coping and 
survival (Bourgois, 2009). Intimate relationships have been theorised as forms of psychic defence 
offering ontological security in hostile and uncertain environments (Beck and Beck-Gernsheim, 1995; 
Giddens, 1992; Rhodes and Cusick, 2000). The intimacy of partnerships between people who use 
drugs constitutes a relatively safe haven, buffering the internalisation of everyday violence, or at 
least cushioning its effects.  
 
Second, while the drug-using partnership is generally cast as a perverse form of care, this care 
produces an alternative emotional capital. According to Reay (2004), emotional capital is the 
capacity to navigate the emotional suffering produced by differentiation or a falling short of 
expectation. The care enacted through intimate drug-using partnerships generates emotional capital 
for negotiating the harms attendant upon difficult and stigmatising social conditions. This then, is an 
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enactment of care negotiated in relation to what is afforded by social conditions (Mol, 2008). Here, 
care extends beyond the pragmatics of enabling a partnership in which drug use features to an 
ethics or politics regarding how drug users, their relationships, and their care practices should be 
viewed and valued. 
 
Third, whilst drug-using couples’ accounts of their partnership care can be viewed as acts of defence 
or resistance against a norm unaccepting of drug-using partnerships,  the care they enact appears in 
large part a coping response to managing emotional and material harms. The everything-together 
dimension of these affective care practices seeks to combat social stigma, but paradoxically may 
entrench it by reproducing the social isolation it seeks to manage. Importantly, although such 
partnerships may function to manage the felt effects of pervasive stigma or lack of access to 
employment and housing, they do not transform these relations through social change. Here, 
intimacy insulates from harm; it does not fundamentally alter structural relations.  
 
Lastly, a core feature of the narration of care in partnerships in our data is its double edge. The 
everything-together approach of mutual reliance which makes up the care relation was also 
presented as potentially entrenching undesirable drug use patterns and dangers. These tensions – 
for instance, in pooling resources to purchase and use drugs and prevent withdrawal, and in 
entrapping both partners in continued drug use – were also voiced via the language of co-
dependency. Accounts of drug-using partnership thus seek to negotiate, even possibly transform, 
their social representations. Through their critical engagement with normative representations of 
care in relation to the drug user and the drug-using couple, the accounts enact alternative care 
meanings and affect relations. It means that the care enacted is an effect of how discursive relations 
are played out in everyday life (Wetherell, 2012; Goodwin, 2000).  
 
Taken together, these findings suggest a need for wider appreciation of how partnerships between 
people who use drugs enact affective care capital in response to social conditions and not merely in 
response to individual circumstances (linked to health or otherwise). This extends the scope of 
couple-based interventions beyond that currently envisaged by public health research (El-Bassel et 
al., 2012). For instance, interventions of social protection may be envisaged that enable the 
development of emotional capital through strategies of stigma management. There is a concomitant 
need, of course, for structural interventions to shift both the discursive and material dynamics of the 
social relations which make up, as well as limit, such potential. 
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In this article we have envisaged the relational effects of partnership care as the coming together of 
people, substances, discourses, and situations (Wetherell, 2012). Perhaps unsurprisingly, participant 
accounts tend to reify the object of the drug as a critical actor in drug relationships and everyday 
relationship troubles. We can, however, see partnership care enactments as made up of a network 
of situated connections, including the patterning together of substances, feelings, interactions, 
narratives, and ways of life. In future research efforts, there is a need to move from “singling out one 
actor” in the relationship – usually the consuming subject – to “acknowledging the agency of the 
myriad additional actors involved” (Duff, 2012: 155). This implies a shift in intervention mentality 
from rational to relational actors (Law, 2004); that is, from individuals to couples to relationship 
networks. 
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Couple Pseudonym Age Ethnicity Hepatitis C status Income source Current relationship durationPrimary drug use
SITE 1
1a Demi 34 Filipino Negative (post-TX) Disibility support 1 year Ice (crystalline methamphetamine)
1b Dean 34 German, Croatian, Serbian.Negative (post-TX) Disibility support 1 year Ice
2a Patrick 52 Anglo-NZ Positive Disibility support 20 years Heroin
2b Pam 50 Greek Cypriot Negative Newstart 20 years Heroin
3a Cameron 39 Aboriginal Negative Full time 9 years Heroin
3b Camila 39 Aboriginal Negative (cleared) Sole parent benefit 9 years Heroin
4a Natalie 43 Anglo-Australian Negative Disibility support 3 years Heroin
4b Nigel 34 Anglo-Australian Positive Cut-off Newstart, currently car windscreen washing3 ye rs Heroin
5a Mindy 39 Anglo-Australian Positive Newstart 10 months Ice
5b Mac 35 Anglo-Australian Negative (post-TX) Disibility support 10 months Ice
6a Samantha 39 Australian; Yugoslavian parentsPositive Disibility support 5 years Ice
6b Simon 42 Anglo-Australian Positive Disibility support 5 years Heroin
7a Clare 46 Australian, Norwegian fatherPositive Disibility support 20 years Heroin
7b Cliff 58 English Positive Disability support; part-time cash-in-hand20 ye rs Heroin
8a Les 55 NZ; Scandinavian & Italian parentsPositive Disability support 1 year Ice
8b Libby 26 Aboriginal Negative Disability support 1 year Ice
9a Fran 31 Anglo-Australian Negative Disability support 1.5 years Heroin/Cocaine
9b Fred 34 Anglo-Australian Positive Disability support 1.5 years Heroin/Cocain/Ice 
10a Andy 38 Anglo-Australian Positive Disability support 10 years ('on & off')Opiates 
10b Angie 36 Anglo-Australian Negative Disability support 10 years ('on & off')Cocaine
11a Janine 48 Anglo-Australian Negative (cleared) Full time 15 years Heroin
11b Jim 61 Anglo-New Zealander Positive None, supported by partner15 years Heroin
12a Rachel 30 Anglo-Australian Positive Newstart 8 years Heroin
12b Roger 33 Greek-Irish Negative Disability support 8 years Heroin
13a Christine 26 Australian (Indigenous heritage on father's side but does not identify)Positive Not disclosed ~ 2.5 years Heroin
13b Craig 29 Anglo-Australian Positive Newstart ~ 2.5 years Heroin
14a Charlie 34 Anglo-Australian Negative Full time work 10 years Heroin
14b Crissy 30 Anglo-NZ Negative (seronverted, then cleared)Disability support  10 years Heroin
15a Tanya 23 Anglo-Australian Positive Disability support 8-9 years ('on & off')Oxycodone
15b Tim 39 Hungarian Negative Disability support 8-9 years (on & off)Morphine
16a Seth 34 Indian Positive Disability support 2 years Heroin
16b Suzie 47 Aboriginal Positive Disability support 2 years Heroin
17a Barbara 28 Anglo-Aust Negative Disability support 5 years Heroin
17b Brian 28 Anglo-Aust Negative Newstart 5 years Heroin
18s Christopher 29 Australian-Lebanese Negative Newstart 2 years Heroin
19a Matilda 20 UK-China Negative (never tested)Youth Allowance 2 months Heroin
19b Matt 23 Anglo-Australian Negative Youth Allowance 2 months Heroin
20s Josh 21 Aboriginal Negative Newstart 6 months Oxycodone
21a Elias 26 Filipino Negative Newstart 5 years Heroin
21b Elena 24 Anglo-Australian Negative Disability support 5 years Heroin
SITE 2
1a Sean 41 Anglo-Australian Positive None 8 years
1b Sandra 40 Anglo-Australian Positive Disability support 8 years
2a Keith 40 Indigenous Positive Disability support 8 years
2b Karen 32 Indigenous Negative (cleared) Disability support 7/8 years
3a Jenn 31 Armenian Australian Positive Disability support 6/7 years
3b Jim 32 Greek/Italian Positive Unemployment benefit 6 years
4a Grace 43 British Negative (cleared) Disability support 6 months (known for 15years)Marijuana (stopped injecting 2 years ago)
4b Glenn 41 Anglo-Australian Positive New Start 3 months (known for 12 yearsIce
5a Janet 24 Anglo-Australian Negative Part time  8 months Heroin
5b Jack 23 Anglo-Australian Negative Unemployment benefit + Market research7/8 month Heroin
6a Mandy 45 Anglo-Austrialian Positive Disability Support 3.5 years Heroin
6b Mike 37 Anglo-Australian Positive Disability support 3.5 years Heroin, Ice and Amphetamine
7a Shelly 34 Anglo-Austrialian Positive Part time work Heroin
7b Steve 33 Anglo-Austrailian Negative (cleared post-TX)Part time work 8 years Heroin
8a Belinda 36 Anglo-Austrialian Positive Disability support 10 years Heroin
8b Bob 46 Greek-Australian Positive Disability support Heroin
9a Debbie 33 Aboriginal Positive Disability support 14 years Heroin
9b Dan 33 Aboriginal Positive Centrelink 14 years Heroin
10a Cath 31 Aboriginal Negative Newstart 8/9 years Heroin
10b Colin 29 Aboriginal Negative Newstart 8 years Heroin
11a Robert 42 Ango-Australian Positive Newstart 8/9 years Heroin
11b Rachel 41 Ango-Australian Positive Disability support Heroin
12a Ava 33 Anglo-Australian Negative (cleared) Not disclosed Heroin
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ACCEPTED MANUSCRIPT12b Alan 48 Anglo-Australian Positive Centrelink 1 yr Heroin
13a Tegan 38 Aboriginal Positive None 6.5years Heroin
13b Terry 37 Aboriginal Negative Newstart 5/6 years Heroin
14a Erin 44 Anglo-Aust Positive Disability support 4 years Heroin
14b Ed 46 Anglo-Aust Negative Centrelink 4 years Heroin
15s Walter 23 Aboriginal Positive Youth allowance Ice
16s Emma 24 Australian Negative Centrelink, and sex work10 months Amphetamine
17s Louise 29 British/Australian Negative Disability support Ice and Amphetamine
18a Fran 29 Australian-Armenian Positive Disability support 7/8 years Heroin
18b Fred 29 Greek-Australian Positve Disability support 8 years Heroin
19s Laura 25 Ango-Australian Positive Centrelink (now stopped)4 years ('on and off')Heroin
20s Gareth 28 Aboriginal Positive Disability support 2 years Heroin
21s Natalie 19 Aboriginal Negative (cleared) Newstart 4 years Ice
22s Jane 29 Vietnamese/Cambodian Positive Not disclosed 9/10 months Heroin
23s Lisa 24 Aboriginal Negative Full time work 5 .5 years Heroin
24s William 27 Ango-Australian Positive Centrelink 2 months Heroin
25s Ken 20 Aboriginal Positive Disability support Ice
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Ice (crystalline methamphetamine)
Marijuana (stopped injecting 2 years ago)
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RESEARCH HIGHLIGHTS 
Uses qualitative research to explore how care is enacted in intimate partnerships 
Shows how drug-users’ intimate partnerships act as sites of social protection 
Finds that ‘doing everything together’ is a key dynamic of care of drug-using couples 
Shows how drug users’ partnerships negotiate tensions between care and harm   
Advocates for a relational approach in understanding the dynamics of affective practices 
